Ethylmorphine metabolism in isolated rat hepatocytes. 1993

B Q Xu, and A Bjørneboe, and A Ripel, and T A Aasmundstad, and A S Christophersen, and J Mørland
National Institute of Forensic Toxicology, Oslo, Norway.

The metabolism of ethylmorphine has been studied in suspensions of isolated rat hepatocytes. Early during incubation, the two major metabolic intermediates detected were morphine and norethylmorphine following N- and O-dealkylation of ethylmorphine, respectively. During subsequent incubation the concentration of the second metabolic intermediate, normorphine increased, before the concentration peaked at approximately 20 microM (100 microM ethylmorphine). Both morphine and normorphine were glucuronidated to form morphine-3-glucuronide and normorphine-3-glucuronide, respectively, which appeared to be the major metabolic end products. The percentage of ethylmorphine metabolized to morphine-3-glucuronide was found to be dependent on the initial concentration of ethylmorphine. With increasing initial ethylmorphine concentration the relative formation of morphine-3-glucuronide was reduced (29 +/- 10% at 5 microM, 18 +/- 5% at 20 microM, and 15 +/- 4% at 100 microM mean +/- S.D., n = 10). The concentrations of ethylmorphine and its metabolites were found to be higher in liver cells than in medium. Thus the ratios between the intra-/extra-cellular concentrations of ethylmorphine increased somewhat from an initial value of 4 during the period for which ethylmorphine could be detected intracellularly. The drug metabolites all exhibited ratios above 10 for the initial 100 min. of incubation. With time these ratios showed a decline, but even for prolonged incubation the ratios were 5 or higher for the end products. Thus considerable drug concentration gradients existed across the cell membrane of isolated rat hepatocytes.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009022 Morphine Derivatives Analogs or derivatives of morphine. Morphines
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005036 Ethylmorphine A narcotic analgesic and antitussive. It is metabolized in the liver by ETHYLMORPHINE-N-DEMETHYLASE and used as an indicator of liver function. Ethomorphine,Dionine,Ethylmorphine Hydrochloride, (5alpha,6alpha)-Isomer,Ethylmorphine Hydrochloride, Dihydrate, (5alpha,6alpha)-Isomer,Ethylmorphine Sulfate (2:1), (5alpha,6alpha)-Isomer,Ethylmorphine, (5alpha,6beta)-Isomer,Trachyl
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

B Q Xu, and A Bjørneboe, and A Ripel, and T A Aasmundstad, and A S Christophersen, and J Mørland
July 1976, Biochemical pharmacology,
B Q Xu, and A Bjørneboe, and A Ripel, and T A Aasmundstad, and A S Christophersen, and J Mørland
January 1978, Biochemical pharmacology,
B Q Xu, and A Bjørneboe, and A Ripel, and T A Aasmundstad, and A S Christophersen, and J Mørland
December 2001, American journal of physiology. Endocrinology and metabolism,
B Q Xu, and A Bjørneboe, and A Ripel, and T A Aasmundstad, and A S Christophersen, and J Mørland
January 1985, European journal of drug metabolism and pharmacokinetics,
B Q Xu, and A Bjørneboe, and A Ripel, and T A Aasmundstad, and A S Christophersen, and J Mørland
November 1977, Canadian journal of biochemistry,
B Q Xu, and A Bjørneboe, and A Ripel, and T A Aasmundstad, and A S Christophersen, and J Mørland
January 1990, Methods in enzymology,
B Q Xu, and A Bjørneboe, and A Ripel, and T A Aasmundstad, and A S Christophersen, and J Mørland
August 1984, The Biochemical journal,
B Q Xu, and A Bjørneboe, and A Ripel, and T A Aasmundstad, and A S Christophersen, and J Mørland
July 1987, Xenobiotica; the fate of foreign compounds in biological systems,
B Q Xu, and A Bjørneboe, and A Ripel, and T A Aasmundstad, and A S Christophersen, and J Mørland
April 1981, Canadian journal of physiology and pharmacology,
B Q Xu, and A Bjørneboe, and A Ripel, and T A Aasmundstad, and A S Christophersen, and J Mørland
September 1969, Biochemical pharmacology,
Copied contents to your clipboard!